Bellerophon Therapeutics, Inc. Operating Cash Flow
Bellerophon Therapeutics, Inc. reported Operating Cash Flow of -$7.99 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-11-14
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$6.33M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$4.92M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was $3.27M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$4.35M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$17.77M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$22.82M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$19.88M.
- Bellerophon Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$12.94M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | -$6.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$11.25M derived: sum of 2 quarters · filed 2023-11-14 | -$7.99M 10-Q · filed 2023-11-14 | -$12.34M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2023-06-30 | -$4.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.66M 10-Q · filed 2023-08-14 | -$6.01M derived: sum of 3 quarters · filed 2023-08-14 | -$11.02M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2023-03-31 | $3.27M 10-Q · filed 2023-05-15 | -$1.09M derived: sum of 2 quarters · filed 2023-05-15 | -$6.10M derived: sum of 3 quarters · filed 2023-11-14 | -$9.77M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-12-31 | -$4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.36M derived: sum of 2 quarters · filed 2023-11-14 | -$13.03M derived: sum of 3 quarters · filed 2023-11-14 | -$17.77M 10-K · filed 2023-03-31 | |
| 2022-09-30 | -$5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$8.68M derived: sum of 2 quarters · filed 2023-11-14 | -$13.42M 10-Q · filed 2023-11-14 | -$17.40M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$8.41M 10-Q · filed 2023-08-14 | -$12.39M derived: sum of 3 quarters · filed 2023-08-14 | -$17.97M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$4.74M 10-Q · filed 2023-05-15 | -$8.71M derived: sum of 2 quarters · filed 2023-05-15 | -$14.30M derived: sum of 3 quarters · filed 2023-05-15 | -$19.67M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.56M derived: sum of 2 quarters · filed 2023-03-31 | -$14.94M derived: sum of 3 quarters · filed 2023-03-31 | -$22.82M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$10.96M derived: sum of 2 quarters · filed 2022-11-14 | -$18.84M 10-Q · filed 2022-11-14 | -$25.25M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-06-30 | -$5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$13.26M 10-Q · filed 2022-08-15 | -$19.66M derived: sum of 3 quarters · filed 2023-03-31 | -$24.58M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-03-31 | -$7.89M 10-Q · filed 2022-05-11 | -$14.29M derived: sum of 2 quarters · filed 2023-03-31 | -$19.21M derived: sum of 3 quarters · filed 2023-03-31 | -$23.43M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2020-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$11.32M derived: sum of 2 quarters · filed 2023-03-31 | -$15.55M derived: sum of 3 quarters · filed 2023-03-31 | -$19.88M 10-K · filed 2023-03-31 | |
| 2020-09-30 | -$4.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$9.14M derived: sum of 2 quarters · filed 2021-11-15 | -$13.48M 10-Q · filed 2021-11-15 | -$16.37M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-06-30 | -$4.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$8.56M 10-Q · filed 2021-08-05 | -$11.46M derived: sum of 3 quarters · filed 2022-03-31 | -$15.42M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2020-03-31 | -$4.34M 10-Q · filed 2021-05-11 | -$7.23M derived: sum of 2 quarters · filed 2022-03-31 | -$11.19M derived: sum of 3 quarters · filed 2022-03-31 | -$14.93M derived: sum of 4 quarters · filed 2022-03-31 | |
| 2019-12-31 | -$2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$6.85M derived: sum of 2 quarters · filed 2022-03-31 | -$10.60M derived: sum of 3 quarters · filed 2022-03-31 | -$12.94M 10-K · filed 2022-03-31 | |
| 2019-09-30 | -$3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$7.70M derived: sum of 2 quarters · filed 2020-11-05 | -$10.04M 10-Q · filed 2020-11-05 | -$14.10M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$6.08M 10-Q · filed 2020-08-05 | -$10.14M derived: sum of 3 quarters · filed 2021-03-11 | -$15.52M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | -$2.34M 10-Q · filed 2020-05-11 | -$6.40M derived: sum of 2 quarters · filed 2021-03-11 | -$11.77M derived: sum of 3 quarters · filed 2021-03-11 | -$17.39M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$9.43M derived: sum of 2 quarters · filed 2021-03-11 | -$15.05M derived: sum of 3 quarters · filed 2021-03-11 | -$15.49M 10-K · filed 2021-03-11 | |
| 2018-09-30 | -$5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$10.99M derived: sum of 2 quarters · filed 2019-11-06 | -$11.44M 10-Q · filed 2019-11-06 | -$15.93M derived: sum of 4 quarters · filed 2020-04-06 | |
| 2018-06-30 | -$5.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$6.06M 10-Q · filed 2019-08-08 | -$10.56M derived: sum of 3 quarters · filed 2020-04-06 | -$13.79M derived: sum of 4 quarters · filed 2020-04-06 | |
| 2018-03-31 | -$444.00K 10-Q · filed 2019-05-09 | -$4.94M derived: sum of 2 quarters · filed 2020-04-06 | -$8.17M derived: sum of 3 quarters · filed 2020-04-06 | -$12.68M derived: sum of 4 quarters · filed 2020-04-06 | |
| 2017-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | -$7.73M derived: sum of 2 quarters · filed 2020-04-06 | -$12.24M derived: sum of 3 quarters · filed 2020-04-06 | -$15.90M 10-K · filed 2020-04-06 | -$15.74M 10-K · filed 2018-03-15 |
| 2017-09-30 | -$3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$7.74M derived: sum of 2 quarters · filed 2018-11-07 | -$11.40M 10-Q · filed 2018-11-07 | -$13.82M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$8.17M 10-Q · filed 2018-08-01 | -$10.59M derived: sum of 3 quarters · filed 2019-03-14 | ||
| 2017-03-31 | -$3.66M 10-Q · filed 2018-05-10 | -$6.08M derived: sum of 2 quarters · filed 2019-03-14 | |||
| 2016-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$17.21M 10-K · filed 2019-03-14 | -$17.46M 10-K · filed 2018-03-15 | ||
| 2016-09-30 | -$14.79M 10-Q · filed 2016-11-08 | ||||
| 2015-12-31 | -$17.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$46.26M 10-K · filed 2018-03-15 | |||
| 2015-09-30 | -$28.97M 10-Q · filed 2016-11-08 |